Jounce Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Jounce Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2018 to Q1 2022.
  • Jounce Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.16M, a 22.3% decline year-over-year.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $4.67M, a 4.66% decline from 2021.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $4.9M, a 21.7% increase from 2020.
  • Jounce Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $4.02M, a 5.76% decline from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.16M -$333K -22.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $1.49M +$402K +36.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $1.09M +$30K +2.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $1.06M +$1.06M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.